Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Norfenefrine: Difference between pages

(Difference between pages)
Page 1
Page 2
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 456636462 of page Norfenefrine for the Chem/Drugbox validation project (updated: 'CAS_number').
 
consistent citation formatting
 
Line 1: Line 1:
{{Short description|Sympathomimetic drug}}
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Norfenefrine|oldid=456636462}} 456636462] of page [[Norfenefrine]] with values updated to verified values.}}
{{Infobox drug
{{Drugbox
| Verifiedfields = changed
| Verifiedfields = changed
| verifiedrevid = 462263073
| Watchedfields = changed
| IUPAC_name = 3-(2-Amino-1-hydroxyethyl)phenol
| verifiedrevid = 408778577
| IUPAC_name = 3-(2-amino-1-hydroxyethyl)phenol
| image = Norfenefrine.png
| image = Norfenefrine.png
| image2 = (R)-Norfenefrine molecule ball.png
| alt2 = Ball-and-stick model of (R)-Norfenefrine


<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
| Drugs.com = {{drugs.com|international|norfenefrine}}
| Drugs.com = {{drugs.com|international|norfenefrine}}
| pregnancy_category =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| legal_status = Rx-only
| pregnancy_US = <!-- A / B / C / D / X -->
| routes_of_administration =
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =


<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
| protein_bound =
| protein_bound =
| metabolism = ''m''-hydroxymandelic acid<ref name="pmid4277715">{{cite journal | vauthors = Hengstmann JH, Konen W, Konen C, Eichelbaum M, Dengler HJ | title = The physiological disposition of p-octopamine in man | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 283 | issue = 1 | pages = 93–106 | year = 1974 | pmid = 4277715 | doi = 10.1007/bf00500148 | s2cid = 35523412 }}</ref><ref>{{cite journal | vauthors = D'Andrea G, Nordera G, Pizzolato G, Bolner A, Colavito D, Flaibani R, Leon A | title = Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages | journal = Neuroscience Letters | volume = 469 | issue = 3 | pages = 348–351 | date = January 2010 | pmid = 20026245 | doi = 10.1016/j.neulet.2009.12.025 | s2cid = 12797090 }}</ref>
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 536-21-0 -->
| CAS_number = 536-21-0
| CAS_supplemental = <br />15308-34-6 ([[hydrochloride]])
| ATC_prefix = C01
| ATC_prefix = C01
| ATC_suffix = CA05
| ATC_suffix = CA05
| PubChem = 4538
| PubChem = 4538
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4379
| ChemSpiderID = 4379
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = D2P3M6SRN5
| UNII = D2P3M6SRN5
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG_Ref = {{keggcite|correct|kegg}}
Line 45: Line 39:


<!--Chemical data-->
<!--Chemical data-->
| C=8 | H=11 | N=1 | O=2
| C = 8 | H = 11 | N = 1 | O = 2
| molecular_weight = 153.178 g/mol
| smiles = OC(c1cc(O)ccc1)CN
| smiles = OC(c1cc(O)ccc1)CN
| synonyms = Norfenephrine<br />Norphenephrine<br />Norphenylephrine<br />''meta''-Norsynephrine<br />''meta''-Octopamine<br />3-Octopamine
| InChI = 1/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2
| InChIKey = LRCXRAABFLIVAI-UHFFFAOYAV
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2
| StdInChI = 1S/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2
Line 55: Line 47:
| StdInChIKey = LRCXRAABFLIVAI-UHFFFAOYSA-N
| StdInChIKey = LRCXRAABFLIVAI-UHFFFAOYSA-N
}}
}}

'''Norfenefrine''' ([[International Nonproprietary Name|INN]]; also known as '''''meta''-octopamine''', '''3-octopamine''', and '''3,β-dihydroxyphenethylamine''') is an [[adrenergic]] [[drug|agent]] used as a [[sympathomimetic]] [[drug]] which is marketed in [[Europe]], [[Japan]], and [[Mexico]].<ref name="Macdonald1997">{{cite book | author = Macdonald F | title = Dictionary of Pharmacological Agents | url = https://books.google.com/books?id=DeX7jgInYFMC&pg=PA104 | access-date = 24 April 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 104 }}</ref><ref name="Index Nominum 2000: International Drug Directory">{{cite book | title = Index Nominum 2000: International Drug Directory | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA750 | access-date = 24 April 2012 | year = 2000 | publisher = Taylor & Francis | isbn = 978-3-88763-075-1 | page = 750 }}</ref> Along with its [[structural isomer]] [[Octopamine|''p''-octopamine]] and the [[tyramine]]s, norfenefrine is a [[natural product|naturally occurring]], [[endogenous]] [[trace amine]] and plays a role as a minor [[neurotransmitter]] in the [[brain]].<ref name="pmid340613">{{cite journal | vauthors = Danielson TJ, Boulton AA, Robertson HA | title = m-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs | journal = Journal of Neurochemistry | volume = 29 | issue = 6 | pages = 1131–1135 | date = December 1977 | pmid = 340613 | doi = 10.1111/j.1471-4159.1977.tb06519.x | s2cid = 26137006 }}</ref>

Some brand names for it include Coritat, Energona, Hypolind, and Novadral.

== See also ==
* [[meta-Tyramine|''m''-Tyramine]]
* [[Phenylephrine]]
* [[Metaraminol]]
* [[Ciclafrine]]

== References ==
{{Reflist}}

{{Cardiac stimulants excluding cardiac glycosides}}
{{Neurotransmitters}}
{{Adrenergic receptor modulators}}
{{TAAR ligands}}
{{Phenethylamines}}

[[Category:Alpha-adrenergic agonists]]
[[Category:Cardiac stimulants]]
[[Category:Norepinephrine-dopamine releasing agents]]
[[Category:Neurotransmitters]]
[[Category:Phenols]]
[[Category:Phenylethanolamines]]
[[Category:TAAR1 agonists]]
[[Category:Trace amines]]

{{nervous-system-drug-stub}}